1,473
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Activating STAT5B mutations can cause both primary hypereosinophilia and lymphocyte-variant hypereosinophilia

, , , , , , & show all
Pages 238-241 | Received 03 Jun 2022, Accepted 22 Sep 2022, Published online: 28 Oct 2022
 

Disclosure statement

AD has received personal consultancy fees from InCycle, EUSA and Loxo, and has received research support from Roche and Takeda. MR participates in a scientific advisory board for and has equity in Auron Therapeutics, Inc., has received research support from Roshe, NGM and Beat AML. MY has received personal consultancy fee from Janssen Research and Development. The remaining authors declare no financial interests. No potential conflict of interest was reported by the author(s).